Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 23, 2020
Vibalogics has initiated Phase I of its planned $150m investment in a late-phase clinical and commercial virotherapy manufacturing facility near Boston, Massachusetts.
read more
Friday, September 02, 2016
Germany-based Vibalogics has expanded its capabilities with a new automatic vial filling line to meet increased demand from biotechnology companies for its specialist live biological manufacturing services for human and veterinary vaccines, gene ...
read more
Vibalogics has increased its single-use bioreactor and purification capacity with a new manufacturing line for its specialist oncolytic virus and viral vector manufacturing services.
read more
Vibalogics will manufacture additional clinical trial material for the lead COVID-19 vaccine candidate currently in development by the Janssen Pharmaceutical Companies of Johnson & Johnson.
read more
Thursday, November 21, 2013
The Vietnam Ministry of Health’s Administration of Science, Technology and Training (ASTT) has signed an agreement with Quintiles to enhance clinical research in this rapidly growing nation of 90 million people, Quintiles announced today.
read more
Thursday, December 16, 2021
Vifor Pharma Group announced the divestment of its finished drug product manufacturing business to CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) of APIs, Excipients, Drug Products, and associated Packaging ...
read more
Wednesday, October 21, 2020
Vifor and Cara announced both companies have signed a license agreement for commercialization of Korsuva (difelikefalin) Injection.
read more
Tuesday, November 29, 2016
Vigene Biosciences, a biotechnology company focused on viral vector production and development, has entered into a definitive agreement to acquire the assets of Omnia Biologics, Inc. (Omnia), including Omnia's cGMP facility and equipment. The ...
read more
ViiV Healthcare and Halozyme Therapeutics, Inc. announced a global collaboration and license agreement that gives exclusive access to Halozyme’s ENHANZE® drug delivery technology, recombinant human hyaluronidase PH20 enzyme (rHuPH20), for specific ...
read more
Tuesday, February 27, 2024
Viking Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced positive top-line results from the company's Phase 2 clinical trial of VK2735, a dual ...
read more
Thursday, August 08, 2013
Vindon, an international company specializing in controlled storage technology for the pharma and biopharma industries, has opened a new facility in Los Angeles, Southern California.
read more
Vindon Scientific (Ireland) Ltd. have made substantial new investment in Ireland’s only IMB certified, GMP compliant Stability Storage Facility at Tramore, County Waterford. Trebling the capacity to 350m³ has enabled Vindon to offer clients stability...
read more
Wednesday, March 13, 2013
Vindon Scientific have commenced manufacture of the controlled environment stability storage rooms to equip its latest storage facility in a move that forms part of Vindon’s recent drive to expand its pharmaceutical and biopharma storage operations. ...
read more
Viracor-IBT Laboratories Inc., a wholly-owned subsidiary of Eurofins Scientific, has announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Zika Virus Real-time RT-PCR assay.
read more
ViraCyte has been awarded $3.75M from National Institutes of Health and the FDA to advance its T cell immunotherapies.
read more